Normal
0
false
false
false
EN-US
X-NONE
AR-SA
MicrosoftInternetExplorer4
Background: Shoulder pain is a common complication of cerebrovascular accidents. This study was conducted to assess the effects
of local injections of bupivacaine and triamcinolone acetate on shoulder joint pain
and on restricted range of motion following brain events.
Methods: This single-blind clinical trial study included 35 patients
with chronic shoulder pain (the controls) and 35 patients
with chronic shoulder pain due to brain events (the case group). The study was
done at Imam Hossein Hospital & Gandhi Day Clinic
during the year 2008-2010. The patients in the
two groups received bupivacaine and triamcinolone acetate for subacromial bursa
injection and suprascapular nerve block by following the protocol described by
Dangoisse et al. The patients were followed up for 12
weeks and they were evaluated for pain and range of motion 1,
6, and 12 weeks after the
injections.
Results: The mean age of the patients was 60.9±9.07
years. Statistically significant improvements in pain score (P=0.001)
and shoulder joint range of motion (P=0.001)
were observed in patients with chronic shoulder pain versus patients with brain
events 12 weeks after
suprascapulare nerve block and subacromial bours injections by bupivacaine and triamcinolone acetate.
Conclusion: Suprascapular
nerve block and subacromial bursa injections of bupivacaine and triamcinolone
acetate is a safe and efficacious treatment for the treatment of chronic shoulder
pain and restricted range of motion but it is not efficacious or of significant
value for the treatment of shoulder pain in patients with brain events.
Rights and permissions | |
![]() |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |